First, in animal models of diet-induced obesity, Withaferin A supplementation reduced hepatic fat, restored hepatic insulin sensitivity, and increased superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and GSH content in the liver [63,64]. Here, CAT is linked to obesity disorder.